Volume 26, Number 6—June 2020
Research
Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department
Table 1
Characteristics of patients, bivariate analysis, and conditional logistic regression of variables potentially associated with colonization by carbapenem-resistant Enterobacteriaceae at ICU admission, Hospital das Clínicas, São Paulo, Brazil, September 2015–July 2017*
Covariate | Bivariate analysis |
Conditional logistic regression |
|||||
---|---|---|---|---|---|---|---|
Cases | Controls | OR (95% CI) | p value | OR (95% CI) | p value | ||
Female sex | 34/103 (33) | 91/201 (45) | 0.58 (0.35–0.95) | 0.03 | |||
Mean age, y (range) |
50.55 (14–84) |
49.78 (4–89) |
1.00 (0.99–1.01) |
0.62 |
|||
Previous hospitalization at ICU admission | |||||||
Previous stay in another unit during hospitalization | 75/101 (74) | 163/201 (81) | 0.84 (0.44–1.60) | 0.60 | |||
Previous stay in the ED during hospitalization | 62/103 (60) | 125/201 (62) | 1.07 (0.65–0.77) | 0.78 | |||
Length of ED stay, d | 2 (0–55) | 1 (0–37) | 1.08 (1.01–1.15) | 0.02 | 1.10 (1.02–1.19) | 0.01 | |
ED stay >2 d | 34/103 (33) | 35/201 (17) | 2.45 (1.40–4.32) | 0.002 | |||
Days of hospitalization before surveillance culture, median (range) | 3 (1–95) | 2 (1–37) | 0.99 (0.99–0.99) | <0.001 | |||
Transfer from another hospital | 43/101 (43) | 51/193 (26) | 2.79 (1.26–3.68) | 0.005 | 2.52 (1.07–5.89) | 0.03 | |
Previous hospitalization |
52/85 (61) |
63/163 (38) |
2.91 (1.53–5.52) |
0.001 |
|||
Clinical characteristics at ICU admission | |||||||
Infection | 63/101 (63) | 82/140 (42) | 2.62 (1.52–4.54) | 0.001 | 1.76 (0.56–5.50) | 0.33 | |
Sepsis | 46/62 (74) | 54/81 (66) | 1.41 (0.52–3.85) | 0.50 | |||
Surgery before ICU admission | 53/102 (52) | 106/194 (55) | 0.92 (0.53–1.62) | 0.78 | |||
Trauma | 8/100 (8) | 25/194 (13) | 0.62 (0.28–1.40) | 0.25 | |||
Stroke |
5/100 (5) |
17/194 (9) |
0.61 (0.17–2.18) |
0.45 |
|||
Severity scores | |||||||
SAPS 3, % median (range) | 22 (4–92) | 16 (0–98) | 1.01 (1.002–1.02) | 0.01 | 1.01 (1.002–1.03) | 0.02 | |
SOFA, median (range) |
5 (0–19) |
5 (0–19) |
1.09 (0.95–1.07) |
0.77 |
|||
Invasive procedures and devices | |||||||
Dialysis | 14/100 (14) | 11/194 (6) | 2.50 (0.97–6.42) | 0.06 | |||
Tracheostomy | 2/99 (2) | 1/194 (0) | 4.92 (0.36–44.67) | 0.26 | |||
Colostomy | 2/99 (2) | 2/194 (1) | 2.00 (0.28–14.34) | 0.49 | |||
Upper digestive endoscopy | 10/101 (10) | 5/194 (3) | 3.70 (1.11–12.32) | 0.003 | 18.9 (1.83–195.98) | 0.01 | |
Colonoscopy | 2/101 (2) | 0/194 (0) | |||||
Parenteral nutrition |
2/101 (2) |
1/ 194 (1) |
3.77 (0.19–74.94) |
0.38 |
|||
Underlying conditions | |||||||
CCI score, mean (range) | 3.10 (0–9) | 2.98 (0–11) | 0.99 (0.96–1.02) | 0.48 | |||
Smoking | 25/62 (40) | 46/137 (34) | 1.17 (0.49–2.78) | 0.72 | |||
Diabetes mellitus | 20/102 (20) | 44/198 (22) | 0.86 (0.46–1.62) | 0.65 | |||
Malignant neoplasm | 9/102 (9) | 23/198 (12) | 0.77 (0.35–1.70) | 0.52 | |||
Rheumatologic or autoimmune disease | 11/102 (11) | 16/198 (8) | 1.44 (0.66–3.15) | 0.36 | |||
Cirrhosis | 15/102 (15) | 11/198 (5) | 2.25 (0.85–5.91) | 0.10 | |||
Chronic kidney disease | 12/102 (12) | 14/198 (7) | 1.51 (0.56–3.99) | 0.40 | |||
Solid organ transplant | 8/102 (8) | 16/198 (8) | 0.62 (0.23–1.64) | 0.33 | |||
HIV infection | 3/100 (3) | 7/198 (4) | 1.13 (0.27–4.76) | 0.86 | |||
Hematological malignancy | 2/102 (2) | 6/198 (3) | 0.59 (0.13–2.87) | 0.52 | |||
Hematopoietic stem cell transplant |
1/102 (1) |
1/198 (0) |
2.00 (0.12–32.42) |
0.63 |
|||
Antimicrobial drug use | |||||||
Any drug at ICU admission† | 81/99 (81) | 142/193 (71) | 1.56 (0.83–2.91) | 0.161 | |||
Carbapenem at ICU admission† | 25/80 (31) | 12/141 (9) | 3.92 (1.51–10.21) | 0.005 | 4.62 (1.30–16.40) | 0.02 | |
Any drug use in previous 3 mo | 50/72 (69) | 48/145 (33) | 5.38 (2.31–12.53) | <0.001 |
*Values are no. (%) except as indicated. CCI, Charlson Comorbidity Index; ED, emergency department; GCS, Glasgow Coma Scale; ICU, intensive care unit; OR, odds ratio; SAPS 3, Simplified Acute Physiology 3, presented as prediction of mortality risk in percentage; SOFA, Sequential Organ Failure Assessment.
†Initiated >48 h before ICU admission.
Page created: May 18, 2020
Page updated: May 18, 2020
Page reviewed: May 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.